Rosuvastatin/valsartan tablet 20/80 milligrams

Adult dose

Valsartan: For the treatment of essential hypertension, the recommended oral dose is 80 mg once daily. If blood pressure is not adequately controlled, it can be increased to a maximum of 320 mg once daily. For heart failure treatment, the recommended oral dose is 40 mg twice daily, and it can be increased to a maximum of 320 mg once daily. To reduce the risk of death after myocardial infarction, treatment should start with 20 mg twice daily and gradually increase. Rosuvastatin is prescribed based on the effectiveness and tolerance of each component, and dosages should be tailored to individual patients.

Child dose

Safety and efficacy of valsartan have not been established in pediatric patients and adolescents (under 18 years old), thus it should not be administered.

This medication may cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Women of childbearing potential should use appropriate contraceptive methods, and it is safe for pregnant or lactating women not to take this medication. Patients with severely impaired liver or kidney function, muscle diseases, or specific allergy histories should not take this medication. Caution should be exercised for elderly patients or those with hyperkalemia, and patients with mild liver impairment should be closely monitored while on this medication. This medication may cause muscle-related side effects such as myalgia, myopathy, and, rarely, rhabdomyolysis, so patients experiencing muscle pain or weakness should consult a physician immediately. Additionally, symptoms of liver function abnormalities, allergic reactions, and hypotension should be carefully monitored. Interactions may occur when taken with other medications, so patients should inform their healthcare provider of any concurrent medications. In cases of overdose, there is no specific antidote, so patients should seek appropriate treatment at a medical facility immediately. This medication should be stored out of reach of children, and it is safe not to transfer it to other containers. If any unusual symptoms occur during use, patients should immediately consult their healthcare provider for appropriate action.

Serious side effects

Urticaria, angioedema (swelling of the face, lips, throat, tongue, etc.), hepatitis, renal failure, hyperkalemia, shock, syncope, loss of consciousness, rhabdomyolysis, hypotension, angioneurotic edema, acute renal failure, serum sickness, vasculitis, interstitial pneumonia, jaundice, acute severe conditions (sepsis, hypotension, major surgery, trauma, severe metabolic endocrine electrolyte disorders, uncontrolled seizures), Stevens-Johnson syndrome, eosinophilia, and other serious reactions.

Mild side effects

Dyspepsia, nausea, dizziness, headache, conjunctival hemorrhage, constipation, weakness, chest pain, facial edema, peripheral edema, nasopharyngitis, urinary tract infection, bruising, increased levels of serum liver aminotransferases (AST, ALT), increased serum creatine phosphokinase, increased serum potassium, increased gamma-glutamyl transferase, musculoskeletal stiffness, limb pain, hypoesthesia, anxiety, upper respiratory tract infection, pharyngitis, tonsillitis, spinal stenosis, dizziness

This medication is sensitive to light and should be stored in a container that does not let light in. It is best to store it at room temperature, between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance

Brown round film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]